Business Context and Reporting Period
This Form 8-K is a current report filed by India Globalization Capital, Inc. (IGC Pharma, Inc.) on August 25, 2015. The filing documents events occurring at the Company's Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
The primary material change reported is the election of Richard Prins to the Board of Directors as a Class B director, serving until the 2018 annual meeting. Additionally, shareholders ratified the appointment of AJSH & Company as the independent registered public accounting firm for the 2015 fiscal year.
Voting Statistics:
- Total shares outstanding and entitled to vote: 15,016,465
- Total shares voted (in person or by proxy): 11,818,412 (approximately 78.70%)
Proposal 1: Election of Directors (Richard Prins)
- For: 6,066,575
- Withheld: 98,009
- Broker Non-Votes: 5,653,828
Proposal 2: Ratification of Independent Auditor (AJSH & Company)
- For: 11,536,247
- Against: 93,120
- Abstain: 189,045
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the tenure and specific responsibilities of the newly elected director, Richard Prins.
- Confirm the engagement terms and scope of work for the newly ratified auditor, AJSH & Company.
- Review the Company's proxy statement for detailed biographical information on director nominees and the rationale for the auditor selection.
- Note the high number of broker non-votes (5,653,828) relative to the total shares outstanding, which may indicate significant institutional holdings.